Immutep Ltd Adr Stock Market Value
| IMMP Stock | USD 2.73 0.24 8.08% |
| Symbol | Immutep |
Can Biotechnology industry sustain growth momentum? Does Immutep have expansion opportunities? Factors like these will boost the valuation of Immutep. Market participants price Immutep higher when confident in its future expansion prospects. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Immutep demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.45) | Revenue Per Share | Quarterly Revenue Growth 0.095 | Return On Assets | Return On Equity |
Immutep Ltd ADR's market price often diverges from its book value, the accounting figure shown on Immutep's balance sheet. Smart investors calculate Immutep's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Immutep's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Immutep's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immutep is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immutep's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immutep 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immutep's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immutep.
| 11/01/2025 |
| 01/30/2026 |
If you would invest 0.00 in Immutep on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Immutep Ltd ADR or generate 0.0% return on investment in Immutep over 90 days. Immutep is related to or competes with ProQR Therapeutics, Candel Therapeutics, Allogene Therapeutics, Capricor Therapeutics, Editas Medicine, Mereo BioPharma, and Vanda Pharmaceuticals. Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products More
Immutep Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immutep's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immutep Ltd ADR upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.37 | |||
| Information Ratio | 0.1271 | |||
| Maximum Drawdown | 31.54 | |||
| Value At Risk | (5.41) | |||
| Potential Upside | 7.41 |
Immutep Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immutep's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immutep's standard deviation. In reality, there are many statistical measures that can use Immutep historical prices to predict the future Immutep's volatility.| Risk Adjusted Performance | 0.1099 | |||
| Jensen Alpha | 0.6129 | |||
| Total Risk Alpha | 0.3258 | |||
| Sortino Ratio | 0.1834 | |||
| Treynor Ratio | 0.6056 |
Immutep January 30, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1099 | |||
| Market Risk Adjusted Performance | 0.6156 | |||
| Mean Deviation | 3.35 | |||
| Semi Deviation | 2.92 | |||
| Downside Deviation | 3.37 | |||
| Coefficient Of Variation | 716.05 | |||
| Standard Deviation | 4.87 | |||
| Variance | 23.68 | |||
| Information Ratio | 0.1271 | |||
| Jensen Alpha | 0.6129 | |||
| Total Risk Alpha | 0.3258 | |||
| Sortino Ratio | 0.1834 | |||
| Treynor Ratio | 0.6056 | |||
| Maximum Drawdown | 31.54 | |||
| Value At Risk | (5.41) | |||
| Potential Upside | 7.41 | |||
| Downside Variance | 11.36 | |||
| Semi Variance | 8.54 | |||
| Expected Short fall | (4.10) | |||
| Skewness | 2.29 | |||
| Kurtosis | 10.52 |
Immutep Ltd ADR Backtested Returns
Immutep appears to be very risky, given 3 months investment horizon. Immutep Ltd ADR holds Efficiency (Sharpe) Ratio of 0.15, which attests that the entity had a 0.15 % return per unit of risk over the last 3 months. By evaluating Immutep's technical indicators, you can evaluate if the expected return of 0.78% is justified by implied risk. Please utilize Immutep's Downside Deviation of 3.37, market risk adjusted performance of 0.6156, and Risk Adjusted Performance of 0.1099 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Immutep holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of 1.11, which attests to a somewhat significant risk relative to the market. Immutep returns are very sensitive to returns on the market. As the market goes up or down, Immutep is expected to follow. Please check Immutep's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Immutep's current trending patterns will revert.
Auto-correlation | 0.35 |
Below average predictability
Immutep Ltd ADR has below average predictability. Overlapping area represents the amount of predictability between Immutep time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immutep Ltd ADR price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current Immutep price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | 0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Pair Trading with Immutep
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immutep position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will appreciate offsetting losses from the drop in the long position's value.Moving against Immutep Stock
| 0.8 | ACLX | Arcellx | PairCorr |
| 0.73 | RANI | Rani Therapeutics | PairCorr |
| 0.72 | MBIO | Mustang Bio | PairCorr |
| 0.69 | BCT | Briacell Therapeutics | PairCorr |
| 0.68 | CRBP | Corbus Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Ltd ADR to buy it.
The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immutep moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immutep Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immutep can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.